Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Real-World Evidence: Observational Studies Deserve More Respect In US FDA Framework

Apr 30 2019

• By Sue Sutter

High resolution green, fresh and natural 3d conceptual grass over a blue sky background, a opened door at horizon ideal for religion,home,recreation,faith,business,success,oportunity or future — Industry wants an open door for use of observational studies to support efficacy claims. • Source: Shutterstock

Related Content

Real-World Data Could Get Boost From Trial Replication Project

Apr 27 2018

US FDA Is Hesitant About Using Observational Studies In Real-World Evidence Framework

Dec 07 2018

Real-World Evidence Demo Projects From US FDA To Include New Mobile App

Nov 07 2018

Real-World Evidence: US FDA Framework Emphasizes Data Fitness And Study Quality

Dec 09 2018

Related Companies

Johnson & Johnson

Additional Topics

United States Drug Approval Standards Clinical Trials Regulation BioPharmaceutical

More from Approval Standards

More from Pathways & Standards

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.